Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol–Lowering Effect in APOE*3-Leiden Transgenic Mice-Reference-Cited by-同舟云学术

Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol–Lowering Effect in APOE*3-Leiden Transgenic Mice

Published:2003-09-16 Issue:11 Volume:108 Page:1368-1374
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Kleemann Robert¹,Princen Hans M.G.¹,Emeis Jef J.¹,Jukema J. Wouter¹,Fontijn Ruud D.¹,Horrevoets Anton J.G.¹,Kooistra Teake¹,Havekes Louis M.¹

Affiliation:

1. From Gaubius Laboratory, The Netherlands Organization for Applied Scientific Research (TNO)-Prevention and Health, Leiden, The Netherlands (R.K., H.M.G.P., J.J.E., T.K., L.M.H.); Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands (J.W.J.); and Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (R.D.F., A.J.G.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

3. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?;Pharmacological Research;2024-02

2. The effects of statin therapy on aneurysm size, growth rate, and matrix metalloproteinases-9 levels in patients with aortic aneurysm: a systematic review and meta-analysis;The Egyptian Heart Journal;2023-10-13

3. Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation;International Journal of Molecular Sciences;2023-04-25

4. Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice;In Vivo;2023

5. Rosuvastatin alleviates renal injury in cardiorenal syndrome model rats through anti-inflammatory and antioxidant pathways;Emergency and Critical Care Medicine;2022-11-18